期刊文献+

血清睾酮水平在前列腺癌管理中的新认识 被引量:1

The new understanding of serum testosterone level in the management of prostate cancer
下载PDF
导出
摘要 传统观点认为睾酮治疗会促进前列腺癌细胞的生长,所以睾酮治疗不适用于前列腺癌患者,但是最近越来越多的临床研究结果与这一传统认识相悖。目前研究表明,高内源性雄激素水平不增加前列腺癌的发病风险,也不促进前列腺癌患者的疾病进展。雄激素受体的饱和似乎可以解释这种现象;并且对于睾酮缺乏(testosterone deficiency,TD)的前列腺癌患者,睾酮治疗可以改善其生活质量。睾酮在前列腺癌生长和治疗中的作用十分复杂,还需要进一步探索。因此,本文就睾酮与前列腺癌关系的最新研究作一综述。 Traditionally,testosterone therapy can promote the growth of prostate cancer cells,so testosterone therapy is not suitable for prostate cancer patients,but the results of recent researches are contrary to the axiom.The current research indicates that the high endogenous androgen levels do not increase the incidence of prostate cancer and do not contribute to disease progression in prostate cancer patients.Androgen saturation model seems to explain this phenomenon;and for the prostate cancer patients with testosterone deficiency(TD),testosterone therapy can improve the quality of life.The role of testosterone on the growth and treatment of prostate cancer is complex,and further exploration is needed.Therefore,this article reviews the recent research on the relationship between testosterone and prostate cancer.
作者 江杰 梁超 苗陈岿 王增军 邵鹏飞 Jiang Jie;Liang Chao;Miao Chenkui;Wang Zengjun;Shao Pengfei(Department of Urology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2019年第9期1399-1402,共4页 Journal of Nanjing Medical University(Natural Sciences)
关键词 睾酮 饱和模型 睾酮缺乏症 前列腺癌 testosterone saturation model testosterone deficiency prostate cancer
  • 相关文献

参考文献4

二级参考文献73

  • 1Miller LR, Partin AW, Chan DW, et al. Influence of radical prostatec - tomy on serum hormone levels. J Urol, 1998,160 : 449 -453.
  • 2Ghosh PK, Ghosh D, Ghosh P, et al. Effects of prostatectomy on testicular androgenesis and serum levels of gonadotropins in mature albino rats. Prostate, 1995, 26:19-22.
  • 3Lokeshwar BL, Hurkadli KS, Sheth AR, et al. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor, Cancer Res, 1993, 53 : 4855 -4859.
  • 4Madersbacher S, Schatzl G, Bieglmayer C, et at.Impact of radical prostatectomy and TURP on the hypothalamic - pituitary - gonadal hormone axis. Urology, 2002, 60(5): 869-874.
  • 5Walsh PCI. Campbell's Urology, 8th ed. Philadelphia: Saunders, 2002:3003 - 3005.
  • 6Gann PH,Hennekens CH, Ma J, et al. Prospective study of the sex hormone levels and risk of prostate cancer. J Natl Cancer Inst, 1996, 88(4) : 1118 - 1126.
  • 7Ross RK, Pike MC, Coetzee GA, et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res, 1998, 58(2) : 4497 -4504.
  • 8PoIIard M. Lobund - Wistar rat model of prostate cancer in man. Prostate, 1998, 37(8): 1 -4.
  • 9Harper ME, Pierrepoint CG, Griffiths K. Carcinoma of the prostate : relationship of pre - treatment hormone levels to survival. Eur J Cancer Clin Oncol, 1984, 20(3) : 477 -482.
  • 10Abraham Morgentaler. Testosterone replacement therapy and prostaterisks : where's the beef? Can J Urol 2006, 13 ( Suppl 1 ) : 40 - 43.

共引文献11

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部